Den norske Eterfabrikk   Report issue

For profit Phase 1
Founded: Oslo Norway (1900)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2016
NCT02598856
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

A/S Den norske Eterfabrikk